These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 19687452)

  • 1. Absence of ubiquitinated inclusions in hypocretin neurons of patients with narcolepsy.
    Honda M; Arai T; Fukazawa M; Honda Y; Tsuchiya K; Salehi A; Akiyama H; Mignot E
    Neurology; 2009 Aug; 73(7):511-7. PubMed ID: 19687452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized loss of hypocretin (orexin) cells in narcolepsy without cataplexy.
    Thannickal TC; Nienhuis R; Siegel JM
    Sleep; 2009 Aug; 32(8):993-8. PubMed ID: 19725250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Narp immunostaining of human hypocretin (orexin) neurons: loss in narcolepsy.
    Blouin AM; Thannickal TC; Worley PF; Baraban JM; Reti IM; Siegel JM
    Neurology; 2005 Oct; 65(8):1189-92. PubMed ID: 16135770
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern of hypocretin (orexin) soma and axon loss, and gliosis, in human narcolepsy.
    Thannickal TC; Siegel JM; Nienhuis R; Moore RY
    Brain Pathol; 2003 Jul; 13(3):340-51. PubMed ID: 12946023
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reduced number of hypocretin neurons in human narcolepsy.
    Thannickal TC; Moore RY; Nienhuis R; Ramanathan L; Gulyani S; Aldrich M; Cornford M; Siegel JM
    Neuron; 2000 Sep; 27(3):469-74. PubMed ID: 11055430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant loss of dynorphin, NARP, and orexin in narcolepsy.
    Crocker A; España RA; Papadopoulou M; Saper CB; Faraco J; Sakurai T; Honda M; Mignot E; Scammell TE
    Neurology; 2005 Oct; 65(8):1184-8. PubMed ID: 16247044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Narcolepsy: selective hypocretin (orexin) neuronal loss and multiple signaling deficiencies.
    Bassetti CL
    Neurology; 2005 Oct; 65(8):1152-3. PubMed ID: 16247037
    [No Abstract]   [Full Text] [Related]  

  • 8. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system.
    Nishino S; Kanbayashi T
    Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcolepsy: a neurodegenerative disease of the hypocretin system?
    van den Pol AN
    Neuron; 2000 Sep; 27(3):415-8. PubMed ID: 11055422
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypothalamic immunopathology in anti-Ma-associated diencephalitis with narcolepsy-cataplexy.
    Dauvilliers Y; Bauer J; Rigau V; Lalloyer N; Labauge P; Carlander B; Liblau R; Peyron C; Lassmann H
    JAMA Neurol; 2013 Oct; 70(10):1305-10. PubMed ID: 23939463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced hypothalamic gray matter in narcolepsy with cataplexy.
    Buskova J; Vaneckova M; Sonka K; Seidl Z; Nevsimalova S
    Neuro Endocrinol Lett; 2006 Dec; 27(6):769-72. PubMed ID: 17187022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients.
    Cvetkovic-Lopes V; Bayer L; Dorsaz S; Maret S; Pradervand S; Dauvilliers Y; Lecendreux M; Lammers GJ; Donjacour CE; Du Pasquier RA; Pfister C; Petit B; Hor H; Mühlethaler M; Tafti M
    J Clin Invest; 2010 Mar; 120(3):713-9. PubMed ID: 20160349
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Tribbles Pseudokinase 2 (TRIB2)-Immunization Modulates Hypocretin/Orexin Neuronal Functions.
    Tanaka S; Honda Y; Honda M; Yamada H; Honda K; Kodama T
    Sleep; 2017 Jan; 40(1):. PubMed ID: 28364459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IGFBP3 colocalizes with and regulates hypocretin (orexin).
    Honda M; Eriksson KS; Zhang S; Tanaka S; Lin L; Salehi A; Hesla PE; Maehlen J; Gaus SE; Yanagisawa M; Sakurai T; Taheri S; Tsuchiya K; Honda Y; Mignot E
    PLoS One; 2009; 4(1):e4254. PubMed ID: 19158946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The number of hypothalamic hypocretin (orexin) neurons is not affected in Prader-Willi syndrome.
    Fronczek R; Lammers GJ; Balesar R; Unmehopa UA; Swaab DF
    J Clin Endocrinol Metab; 2005 Sep; 90(9):5466-70. PubMed ID: 15985489
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypocretin and melanin-concentrating hormone in patients with Huntington disease.
    Aziz A; Fronczek R; Maat-Schieman M; Unmehopa U; Roelandse F; Overeem S; van Duinen S; Lammers GJ; Swaab D; Roos R
    Brain Pathol; 2008 Oct; 18(4):474-83. PubMed ID: 18498421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies in narcolepsy-cataplexy patient serum bind to rat hypocretin neurons.
    Knudsen S; Mikkelsen JD; Jennum P
    Neuroreport; 2007 Jan; 18(1):77-9. PubMed ID: 17259865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiologic basis of secondary narcolepsy and hypersomnia.
    Kanbayashi T; Sagawa Y; Takemura F; Ito SU; Tsutsui K; Hishikawa Y; Nishino S
    Curr Neurol Neurosci Rep; 2011 Apr; 11(2):235-41. PubMed ID: 21298561
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypocretin/orexin and narcolepsy: new basic and clinical insights.
    Nishino S; Okuro M; Kotorii N; Anegawa E; Ishimaru Y; Matsumura M; Kanbayashi T
    Acta Physiol (Oxf); 2010 Mar; 198(3):209-22. PubMed ID: 19555382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of lateral hypothalamic lesion with the neurotoxin hypocretin-2-saporin on sleep in Long-Evans rats.
    Gerashchenko D; Blanco-Centurion C; Greco MA; Shiromani PJ
    Neuroscience; 2003; 116(1):223-35. PubMed ID: 12535955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.